Maravai LifeSciences Holdings Inc. has announced a change in its certifying accountants, appointing Deloitte & Touche LLP as its new independent registered public accounting firm for the fiscal year ending December 31, 2025. This decision, approved by the company's Audit Committee, follows the dismissal of Ernst & Young LLP. During the fiscal years 2023 and 2024, Ernst & Young reported material weaknesses in Maravai's internal control over financial reporting, particularly concerning revenue, accounts receivable, and goodwill impairment. These issues were outlined in Maravai's 2024 annual report. The Audit Committee has ensured that Deloitte is fully informed about these weaknesses to facilitate a smooth transition.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。